•  
  •  
 

Document Type

Original Article

Abstract

Background: Cataract is leading reason for blindness in all years old groups in North Africa & Middle East. Cataract was leading reason for reversible blindness worldwide between 1990 & 2010, accounting for nearly half of all cases.  Most common cataract surgery method is phacoemulsification with IOL.

Aim of the Work: To assess commercially available, locally manufactured intraocular lenses Aqualens® (AH612AL) regarding quality, clinical biocompatibility and complications.

Studied cases & techniques: This prospective, interventional research involved thirty eyes with senile cataract. Patients were collected from the Ophthalmology Department, Faculty of Medicine, Al-Azhar University at time from March 2021 to March 2022.

Results: This study included thirty eyes with senile cataract operated by phaco-emulsification and implantation of IOL (Aqualens®, AH612AL). They were 11 males (36.7%) and 19 females (63.3%). The operated eyes were 16 right eye (OD) (53.3%) and 14 eyes (46.7%) were left (OS). The present research finds that there was no variation found among 48 hours and 1 week and also 1 month regarding PCO grading with p-value = 1.000 & 0.075; while there was rise in the PCO grading at 3 month and 6 months than 48 hours postoperative with p = 0.009 &

Conclusion: this research demonstrated that the optical quality of Aqualens®, AH612AL IOL has satisfactory results and significant improvement in regard to incidence of PCO formation, flare reaction, cell deposits, cystoid macular edema, aberrations, stability and visual acuity

Keywords

AH612AL; FDA; Pseudoexfoliation; IOLs; PMA.

Subject Area

Ophthalmology

Download

Share

COinS